K-V Pharma (KV-A) Move Higher, May Be Related to Roche (RHHBY) News
Tweet
Share
E-mail
K-V Pharmaceutical Company (NYSE: KV-A)(NYSE: KV-B) shares keep moving higher Friday, now up 13.5 percent.
The move might be related to the FDA issuing a letter revoking Roche's (OTCBB: RHHBY) Avastin breast cancer indication.
The move might be related to the FDA issuing a letter revoking Roche's (OTCBB: RHHBY) Avastin breast cancer indication.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- Keenova doses first patient in Phase 3 hammer toe drug trial
- Ionis to present olezarsen and ION775 data at ESC Congress 2026
Create E-mail Alert Related Categories
FDA, Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
